Invest

CannaMetrixTM   has exclusively licensed its Cell-based EC50 Array assay for cannabis potency testing to XXII Century Group, Inc. CannaMetrixTM  is committed to the development of quantitative methods that determine full and broad spectrum cannabis products’ potencies relative to key cellular biomarkers as means of developing treatments with the greatest health and medical impact.  The company also is interested in applying the same rigor to potency testing to other plant-based or nutritional supplements.  Our goal is to better differentiate products in the marketplace for consumers based on the biologically relevant interactions that critical components in the product have that affect human physiology.